Age-Based Disparity in Outcomes of Intestinal Transplants in Pediatric Patients
Article first published online: 29 MAY 2012
DOI: 10.1111/j.1600-6143.2012.04107.x
© Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons
Issue

American Journal of Transplantation
Special Issue: Focus on Small Bowel Transplantation: Selected Works from the XII International Small Bowl Transplant Symposium
Volume 12, Issue Supplement s4, pages S43–S48, December 2012
Additional Information
How to Cite
Desai, C. S., Maegawa, F. B., Gruessner, A. C., Gruesner, R. W. and Khan, K. M. (2012), Age-Based Disparity in Outcomes of Intestinal Transplants in Pediatric Patients. American Journal of Transplantation, 12: S43–S48. doi: 10.1111/j.1600-6143.2012.04107.x
Publication History
- Issue published online: 26 NOV 2012
- Article first published online: 29 MAY 2012
- Received 05 January 2012, revised 22 March 2012 and accepted for publication 07 April 2012
- Abstract
- Article
- References
- Cited By
Keywords:
- Intestine;
- multivisceral;
- pediatrics;
- survival;
- transplant
Outcomes of intestinal transplants (ITx; n = 977) for pediatric patients are examined using the United Network for Organ Sharing data from 1987 to 2009. Recipients were divided into four age groups: (1) <2 years of age (n = 569), (2) 2–6 years (n = 219), (3) 6–12 years (n = 121) and (4) 12–18 years (n = 68). Of 977 ITx, 287 (29.4%) were isolated ITx and 690 (70.6%) were liver and ITx (L-ITx). Patient survival for isolated ITx at 1, 3 and 5 years, 85.3%, 71.3% and 65.0%, respectively, was significantly better than L-ITx, 68.4%, 57.0% and 51.4%, respectively, (p = 0.0001); this was true for all age groups, except for patients <2 years of age. The difference in graft survival between isolated ITx and L-ITx was significant at 1 and 3 years (Wilcoxon test, p = 0.0012). After attrition analysis of graft survival of patients who survived past first year, 3 and 5 years, graft survival for L-ITx patient was significantly better than those for isolated ITx. Isolated ITx should be considered early before the onset of liver disease in children >2 with intestinal failure but is not advantageous in patients <2 years.

1600-6143/asset/olbannerleft.gif?v=1&s=c46a3f174bfd9c6eb548cc809401524372c32e90)
1600-6143/asset/olbannerright.gif?v=1&s=9fc9790fa8ad5ef85aeaf408bf0d3d969d2fc012)